GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (OTCPK:AKESF) » Definitions » Other Stockholders Equity

Akeso (AKESF) Other Stockholders Equity : $935.9 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Akeso Other Stockholders Equity?

Akeso's Other Stockholders Equity for the quarter that ended in Dec. 2024 was $935.9 Mil.

Akeso's quarterly Other Stockholders Equity declined from Dec. 2023 ($279.8 Mil) to Jun. 2024 ($235.5 Mil) but then increased from Jun. 2024 ($235.5 Mil) to Dec. 2024 ($935.9 Mil).

Akeso's annual Other Stockholders Equity declined from Dec. 2022 ($282.3 Mil) to Dec. 2023 ($279.8 Mil) but then increased from Dec. 2023 ($279.8 Mil) to Dec. 2024 ($935.9 Mil).

Akeso Other Stockholders Equity Historical Data

The historical data trend for Akeso's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akeso Other Stockholders Equity Chart

Akeso Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial 340.75 299.28 282.27 279.82 935.88

Akeso Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 282.27 722.41 279.82 235.45 935.88

Akeso Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Akeso Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Akeso's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Akeso Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (OTCPK:AKESF) » Definitions » Other Stockholders Equity
Comparable Companies
HKSE:01177 HKSE:06990 HKSE:01801 HKSE:01530 HKSE:01877 HKSE:01548 HKSE:02269 HKSE:09995 HKSE:09969 HKSE:02696 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
09926:Hong Kong 4RY:Germany
Address
6 Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437
Website
https://www.akesobio.com
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in USA.